Lutein and Zeaxanthin Supplements Could Save Billions in Healthcare Costs
Age-related macular degeneration (AMD) is a progressive degenerative eye disease and a major cause of vision loss among mature adults. A recent study suggests that consumption of lutein and zeaxanthin supplements could lead to billions of dollars saved per year on health care.
For their analysis, researchers examined incidences of AMD in the European Union (EU). They found that 17.1 million people in the EU live with AMD and that 2.5 million of them are in the severe or late stages of the disease. They then calculated the cost of managing severe or late stage AMD and found that it was an expected $143.14 billion per year.
The researchers then examined studies on the effects of lutein and zeaxanthin on AMD and determined that if EU adults age 50 and older with mild AMD consumed 10 mg of lutein and 2 mg of zeaxanthin daily, they would reduce their risk of transitioning to severe late stage AMD by 7.0%. That translates to a savings of $5.87 billion per year.
Researchers from Frost & Sullivan conducted the study. It was published by Frost & Sullivan in a report called The Economic Benefits of Using Lutein and Zeaxanthin Food Supplements in the European Union.
Lutein and zeaxanthin are the only two carotenoids that can build macular pigment. Lutein and zeaxanthin create the yellow pigmentation of the macula, which is the part of the eye that provides protection from damaging blue light. If the yellow macular pigment is too thin, blue light can penetrate the retina and cause long-term damage.
You can increase your lutein and zeaxanthin levels by consuming more green leafy vegetables, corn, and egg yolk.